Adjuvant Therapies and Patient and Tumor Characteristics Associated With Survival of Adult Patients With Adrenocortical Carcinoma | Zendy

Tobias Else | Zendy; Andrew Williams | Zendy; Aaron Sabolch | Zendy; Shruti Jolly | Zendy; Barbra S. Miller | Zendy; Gary D. Hammer | Zendy

Open Access

Adjuvant Therapies and Patient and Tumor Characteristics Associated With Survival of Adult Patients With Adrenocortical Carcinoma

Author(s) -

Tobias Else,

Andrew Williams,

Aaron Sabolch,

Shruti Jolly,

Barbra S. Miller,

Gary D. Hammer

Publication year - 2013

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2013-2856

Subject(s) - adrenocortical carcinoma , mitotane , medicine , oncology , adrenalectomy , adjuvant therapy , proportional hazards model , stage (stratigraphy) , hazard ratio , radiation therapy , retrospective cohort study , carcinoma , cancer , paleontology , confidence interval , biology

Adrenocortical carcinoma is a rare malignant endocrine neoplasia. Studies regarding outcome and prognostic factors rely on fairly small studies. Here we summarize the experience with patients with a diagnosis of adrenocortical carcinoma from a large tertiary referral center.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research